Table 1.
Sociodemographic and Clinical Characteristics of the Patients in the 2 Treatment Groups
| Characteristics | Ablation Group (n = 82) | AAD Group (n = 84) | P Value |
|---|---|---|---|
| Age, y | 55.9 ± 6.1 | 57.2 ± 5.4 | 0.136 |
| Male sex | 55 (67.1) | 58 (69.1) | 0.785 |
| Partner status (married/partner) | 78 (95.1) | 78 (92.9) | 0.388 |
| Employment status (employed) | 38 (46.3) | 41 (48.8) | 0.750 |
| History of AF (mo) | 90.1 ± 90.1 | 86.9 ± 90.8 | 0.821 |
| Maximum AF duration (min) | 13.5 ± 19.3 | 13.1 ± 19.2 | 0.893 |
| Failed AAD (n) | 2.2 ± 0.9 | 2.0 ± 0.7 | 0.094 |
| LA diameter (mm) | 39.0 ± 5.9 | 38.6 ± 6.2 | 0.733 |
| LVEF (%) | 59.6 ± 7.5 | 58.9 ± 8.3 | 0.573 |
| Hypertension | 53 (64.6) | 51 (60.7) | 0.602 |
| DM | 11 (13.4) | 16 (19.1) | 0.326 |
| CAD | 8 (9.8) | 10 (11.9) | 0.656 |
| Prior stroke/TIA | 7 (8.5) | 7 (8.3) | 0.962 |
| Dilated cardiomyopathy | 2 (2.4) | 4 (4.8) | 0.352 |
| Valvular disease | 3 (3.7) | 5 (6.0) | 0.373 |
Abbreviations: AAD, antiarrhythmic drug; AF, atrial fibrillation; CAD, coronary artery disease; DM, diabetes mellitus; LA, left atrial; LVEF, left ventricular ejection fraction; TIA, transient ischemic attack. Values are presented as mean ± SD or n (%).